Meetings

A deep learning model was able to predict future lung cancer risk from a single low-dose chest CT scan, according to new research published at the ATS 2025 International Conference. 

Microplastics are ubiquitous in the environment, and we all routinely inhale these tiny pollutants. Now new research published at the ATS 2025 International Conference has found that inhaled microplastics suppress pulmonary macrophages, a type of white blood cell found in the lungs that are critical to the immune system.

Adding a team therapist to support nurses in critical care areas can reduce burnout and improve resiliency, according to research published at the ATS 2025 International Conference.

Premature infants are at risk of bronchopulmonary dysplasia, or BPD, a type of lung injury associated with increased mortality. Now a new study published at the ATS 2025 International Conference shows that ciliary dynamics may play a role in the pathophysiology of this disease.

Berlin, Germany – As antibiotic resistance accelerates into a global crisis, phage therapy is emerging as one of the most promising—and urgent—solutions in modern medicine. From June 10–11, 2025, the international scientific and medical community will gather in Berlin for Targeting Phage Therapy 2025, the leading global event focused on translating phage research into clinical reality.

With the theme “From Bench to Bedside: Accelerating Clinical Applications of Phage Therapy”, this year’s program brings together global leaders across infectious diseases, oncology, microbiome science, regulatory affairs, and biotechnology.

Two years ago the United Network for Organ Sharing implemented new allocation guidelines for lung transplants that prioritize medical urgency. Now new research published at the 2025 ATS International Conference shows that waitlist outcomes significantly improved under the new system.

Prednisone is recommended as the first-line treatment for pulmonary sarcoidosis, but this steroid causes a number of unwanted side effects. Now new research published at the ATS 2025 International Conference finds that methotrexate provides a comparable alternative.

A wearable pulse oximeter and connected software platform show promise for monitoring obstructive sleep apnea (OSA) and other sleep-related breathing diseases, according to research presented at the ATS 2025 International Conference.

Rising temperatures increase the severity of obstructive sleep apnea (OSA), according to a large new study published at the ATS 2025 International Conference. The study also found that, under the most likely climate change scenarios, the societal burden of OSA is expected to double in most countries over the next 75 years.

The Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting returns May 28–31, 2025, in Phoenix, AZ, uniting leading MS professionals under the theme “MS Heroes Unite.” The conference features keynote lectures from prominent experts, including Marie Namey, Anthony Feinstein, Riley Bove, and Robert Fox, addressing key topics like holistic MS care, depression, reproductive health, and treatment breakthroughs.

Additional sessions highlight advances in neuroanatomy, fluid biomarkers, fatigue management, genetic predictors, and more. With accredited education, networking, and interdisciplinary dialogue, CMSC Annual Meeting 2025 offers unparalleled insights for the MS care community.